Half-year report · Q2
4885.TEDINET S100V2K6
Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.0bn | 2024-06-01 → 2024-11-30 | Standalone | Net sales |
| Revenue | ¥6.4bn | 2023-06-01 → 2024-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2023-06-01 → 2023-11-30 | Standalone | Net sales |
| Operating income | ¥154m | 2024-06-01 → 2024-11-30 | Standalone | Operating income |
| Operating income | ¥115m | 2023-06-01 → 2023-11-30 | Standalone | Operating income |
| Ordinary income | ¥171m | 2024-06-01 → 2024-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥428m | 2023-06-01 → 2024-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥110m | 2023-06-01 → 2023-11-30 | Standalone | Ordinary income |
| Profit before tax | ¥171m | 2024-06-01 → 2024-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥145m | 2023-06-01 → 2023-11-30 | Standalone | Income before income taxes |
| Net income | ¥121m | 2024-06-01 → 2024-11-30 | Standalone | Profit loss |
| Net income | ¥330m | 2023-06-01 → 2024-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥93m | 2023-06-01 → 2023-11-30 | Standalone | Profit loss |
| Total assets | ¥5.5bn | at 2024-11-30 | Standalone | Assets |
| Total assets | ¥5.1bn | at 2024-05-31 | Standalone | Assets |
| Total assets | ¥5.1bn | at 2023-11-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2024-11-30 | Standalone | Liabilities |
| Total liabilities | ¥2.8bn | at 2024-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.3bn | at 2024-11-30 | Standalone | Net assets |
| Net assets / equity | ¥2.3bn | at 2024-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2024-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2024-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2024-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2023-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥853m | at 2023-05-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥137m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥638m | 2023-06-01 → 2024-05-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥143m | 2023-06-01 → 2023-11-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥188m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥232m | 2023-06-01 → 2024-05-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥115m | 2023-06-01 → 2023-11-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥336m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥210m | 2023-06-01 → 2024-05-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥185m | 2023-06-01 → 2023-11-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥30.29 | 2024-06-01 → 2024-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.42 | 2023-06-01 → 2024-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.63 | 2023-06-01 → 2023-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.82 | 2024-06-01 → 2024-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥81.86 | 2023-06-01 → 2024-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥23.16 | 2023-06-01 → 2023-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥22 | 2023-06-01 → 2024-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 42.2% | at 2024-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.9% | at 2024-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.9% | at 2023-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2024-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2024-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-11-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥17m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥523m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥523m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥5m |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥167m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥3.0bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥3.0bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥154m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.0bn |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.0bn |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | −¥55m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥379m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥379m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | −¥28m |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.5bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.5bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥198m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.9bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.9bn |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥115m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 506
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 1065004000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 1328809000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 1050427000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4095500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4095500 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 4095500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 4095500 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 610000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1525 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 348650 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0871 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 260064 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0650 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 150000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0375 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 131000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0327 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 117450 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0294 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 100000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0250 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 80800 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0202 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 75000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0187 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 75000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0187 | |
| Number of shares held | CurrentQuarterInstant | 1947964 | |
| Shareholding ratio | CurrentQuarterInstant | 0.4869 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 94800 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 3995900 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 39959 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 4800 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 4095500 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 39959 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 94800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 94800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0231 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 94800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 94800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0231 | |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 1050427000 | JPY |
| Cash and deposits | CurrentQuarterInstant_NonConsolidatedMember | 1328809000 | JPY |
| Notes receivable trade | Prior1YearInstant_NonConsolidatedMember | 8921000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |